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Understanding of the structures and functions of the retroviral integrase (IN), a key enzyme in the viral replication cycle, is essential for
developing antiretroviral treatments and facilitating the development of safer gene therapy vehicles. Thus, four MLV IN-mutants were constructed
in the context of a retroviral vector system, harbouring either a substitution in the catalytic centre, deletions in the C-terminus, or combinations of
both modifications. IN-mutants were tested for their performance in different stages of the viral replication cycle: RNA-packaging; RT-activity;
transient and stable infection efficiency; dynamics of reverse transcription and nuclear entry. All mutant vectors packaged viral RNA with wild-
type efficiencies and displayed only slight reductions in RT-activity. Deletion of either the IN C-terminus alone, or in addition to part of the
catalytic domain exerted contrasting effects on intracellular viral DNA levels, implying that IN influences reverse transcription in more than one
direction.
© 2007 Elsevier Inc. All rights reserved.Keywords: MLV; Integrase mutants; Reverse transcription; 2-LTR circles; Real-time PCRIntroduction
The integrase-coding sequence in mammalian gamma-retro-
viruses is located in the 3′-part of the pol gene (Schwartzberg et
al., 1984). The translation product is the large Gag-Pol
polyprotein, which is processed into its active forms by the
viral protease (von der Helm, 1977). The main function of the
mature integrase (IN) is the irreversible insertion of the retroviral
DNA into the host genome. This is accomplished via the
interaction of IN with the viral attachment sites (Panganiban and
Temin, 1983), which are located at the ends of the viral DNA
sequence, followed by cleavage of viral and host DNA, and
consecutive joining and ligation of host and virus sequences (for⁎ Corresponding author. Fax: +43 1 25077 2390.
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In addition, several cellular proteins are probably involved in the
integration process (for a recent review see: Van Maele et al.,
2006). Integration is thought to be an indispensable prerequisite
for stable expression of viral genes and genomic RNA, and
enables the latent infection status typical for retroviruses. The
ability to stably integrate transgenes was the initial driving force
behind development of retroviral and lentiviral vectors for gene
therapy applications (Thomas et al., 2003). However, serious
drawbacks in clinical settings (Kohn et al., 2003), most likely
resulting from low integration site selectivity, have led to
concerns regarding the use of retroviral vectors and warrant
further detailed analysis of the structures and mechanisms
behind the retroviral integration process.
The mature IN protein consists of three distinct domains: an
N-terminal zinc-finger-like H–H–C–C domain, a catalytic
centre comprising an invariant D–D–E motif and a less
conserved C-terminal domain (Katz and Skalka, 1994).
Fig. 1. Schematic representations of the retroviral packaging construct
pGagPol.gpt and derived integrase mutant packaging vectors. LTR: long
terminal repeat; PR, RT, IN: coding regions for the pol-derived enzymes
protease, reverse transcriptase and integrase. pA: polyadenylation signal. The
IN-coding region is subsequently enlarged to demonstrate the changes to wild
type IN in the mutants. WT IN is contained in the parental plasmid pGagPol.
gpt. IND184N contains the indicated amino-acid change at position 184 in IN
(the changed amino acid is shown bold and underlined). IN203M15 has the
same D–N mutation in the catalytic centre plus a nonsense protein sequence
from aa187 to aa203 (shown as a striped box), followed by a stop-codon.
IN392 contains a deletion from aa263 to aa278 in the C-terminus and IN263
has the whole C-terminus except the terminal amino acid removed (deletion
from aa263 to aa407). The picture is not drawn to scale.
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(Cannon et al., 1994; Engelman et al., 1995; Leavitt et al., 1996;
Wiskerchen and Muesing, 1995) or incorrect spacing between
these amino acids (Donehower, 1988; Roth et al., 1990) block
integration in vivo, but not necessarily DNA binding and
processing in vitro. Furthermore, the HHCC motif seems to
promote multimerization of integrase (Ellison et al., 1995;
Zheng et al., 1996). The catalytic core contains the evolutionary
highly conserved D–D–E motif, which seems to catalyze the
phosphodiester transfer reactions, central to the covalent linkage
of viral and host DNA (Engelman and Craigie, 1992; Kulkosky
et al., 1992). Structural analysis suggests that these three acidic
residues are in close proximity to each other in the three-
dimensional form (Bujacz et al., 1995, 1996; Dyda et al., 1994;
Jenkins et al., 1995). Furthermore, residues in close proximity to
this active site are probably involved in specific binding of IN to
viral DNA termini (Esposito and Craigie, 1998). The C-terminal
part of IN exerts non-specific DNA-binding activity (Engelman
et al., 1994; Lutzke et al., 1994; Mumm and Grandgenett, 1991;
Woerner et al., 1992;Woerner andMarcus-Sekura, 1993), which
is probably important for sequence insensitive binding of viral
and host DNA (Katzman and Sudol, 1995). Three conserved
regions have been identified within the C-terminus, two of
which are found in all retroviruses (Cannon et al., 1996). In
MLV, deletion of more than 28 amino acids from the C-terminus
abrogates IN catalytic activity (Jonsson et al., 1996) and viral
replication (Roth, 1991). In avian sarcoma virus, the carboxy-
terminal region contains a nuclear localization domain (Kukolj
et al., 1998).
The aim of this study was to analyse the significance of
different elements of MLV integrase for important steps in the
viral replication cycle in vivo. Therefore, we constructed
several MLV integrase mutants defective in either the catalytic
centre of IN, the C-terminal region, or both. Viral particle
production, RT-activity and infection efficiency of the IN
mutant vectors were tested in comparison to a vector har-
bouring wild type integrase in single-round transduction assays.
Furthermore, the kinetics of reverse transcription and nuclear
entry were analysed using a set of quantitative real-time PCR
assays.
While none of the introduced mutations seemed to subs-
tantially influence particle production, moderate reductions in
RT-activity could be observed. Although all mutants were
integration defective, integration was not completely abo-
lished, which is in accordance with the results of other
groups. Surprisingly, however, only one mutant, containing
an almost complete deletion of the C-terminal domain, was
impaired in the accumulation of late reverse transcription
products, while a mutant with a similar deletion encompass-
ing the complete C-terminus plus part of the catalytic domain
showed normal kinetics of reverse transcription. Nuclear entry
was not influenced by any IN mutation or deletion. These
results corroborate the work of others stating that MLV IN,
independent from its catalytic activity, also has an influence
on reverse transcription and suggest that the molecular basis
for this function might reside in several discrete parts of the
protein.Results
Retroviral vectors harbouring mutations and/or deletions in IN
Based on the plasmid pGagPol.gpt (Markowitz et al., 1988),
which allows wild type expression of MLV Gag and Pol, four
different GagPol expression plasmids were constructed, all
harbouring mutations or deletions in either the catalytic triad
(IND184N), or the C-terminus (IN392, IN263), or a combina-
tion of both (IN203M15) (Fig. 1). The integrase mutant
IND184N contains a point mutation (D–N) in the highly
conserved D-D35E motif in the catalytic core of MLV integrase.
IN392 contains a deletion of 16 amino acids (aa263–aa278)
from the C-terminal region, adjacent to the catalytic centre. In
IN263, the whole C-terminus was deleted (aa263–aa407), with
the exception of the terminal aa408. Finally, IN203M15
contains the same D–N mutation in the catalytic core as
IND184N, but has an additional frame shift mutation (insertion
of a cytosine at bp 6465). The result is a nonsense protein
sequence from aa187 to aa203, after which a stop codon
resulting from the frame shift terminates the protein sequence.
Thus, deletion of the amino acid sequence in IN203M15
extends into the catalytic core.
Retroviral vector preparations were obtained from a three-
component stable vector producing system based on human
embryonic kidney cells (HEK293), which were stably trans-
fected with the expression plasmid pALF (Cosset et al., 1995)
encoding the amphotropic MLV envelope gene (4070A), the
retroviral vector pLXSNEGFP and either the wild type structural
vector pGagPol.gpt or one of the described integrase mutants.
Five different virus producing cell lines (vpc) were generated:
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and 293-IN203M15vpc. The plasmid pLXSNEGFP was
described previously (Klein et al., 1997) and encodes the
enhanced green fluorescent protein (EGFP), plus a SV40-
promoter driven neomycin phosphotransferase gene, enabling
detection of infected cells by FACS analysis as well as by
selecting G418-resistant colonies.
Packaging of viral RNA is not affected by IN mutations
To analyse the significance of the described integrase muta-
tions on viral particle production, 24-h conditioned supernatants
of the five virus producer cell lines were sampled. The egfp-
copy number, reflecting the amount of viral particles in the
supernatant, was determined using a quantitative real-time RT-
PCR assay, as described in Materials and methods.
Comparing the amounts of viral RNA in the supernatant
(Fig. 2A), no producer cell line generated significantly more orFig. 2. (A) Amount of vector particles per ml supernatant, shed by virus
producer cell lines, which stably express the indicated IN-constructs. The
amount of vector particles is inferred from the viral RNA copy number, divided
by two, since the retroviral genome is diploid. Displayed values represent the
means plus standard deviations from two independent harvests of supernatants.
Real-time RT-PCR measurement from each harvested supernatant was
performed in duplicate wells. *The difference between the bars indicated by
the tips of the brackets is statistically significant (P=0.045). (B) RT-activity in
supernatants from virus producer cell lines, as measured by a PERT-assay. RT-
activity is given in picounits per μl supernatant, using purified MoMLV RT as a
standard. Displayed values represent the means plus standard deviations from
two independent harvests of supernatants. PERT-assay from each harvested
supernatant was performed in duplicate wells. *The difference between the bars
indicated by the tips of the brackets is statistically significant (P≤0.030). The
difference between IN-WNT and all IN-mutants is also statistically significant,
but not indicated on the figure for clarity reasons.less viral particles than the 293-WTvpc, with the highest values
obtained from 293-IN263vpc (9.42E+06 virions/ml) and the
lowest from 293-IN203M15vpc (2.75E+06 virions/ml). There-
fore, as judged from the amount of viral RNA, there did not
seem to be a negative influence of the IN-mutations on particle
production. The only statistically significant difference
observed in this dataset confirmed that 293-IND184Nvpc
packaged more viral RNA than 293-IN203M15vpc (P=0.045).
RT-activity in IN-mutant viruses is moderately reduced
RT-activity in viral vector preparations was assayed by
performing a PERT-assay (Lovatt et al., 1999; Pyra et al., 1994),
using the same producer cell supernatants as taken for
determination of viral RNA levels. As can be seen from Fig.
2B, viral supernatant produced from 293-WTvpc exhibited
significantly more RT-activity than all of the IN-mutants. Mean
differences ranged from 4- to 30-fold more RT-activity in IN
WT over IN mutant supernatants. Statistically significant dif-
ferences could also be observed within IN-mutants; they were,
however, all within one log of variation. From these data, we
concluded that the introduced mutations and deletions in IN
affect either the amount of properly processed RT in the virions,
or its activity, or both. However, this negative influence was
rather moderate (well below a 2-log difference) and was even
less when RT-activity was normalized to viral RNA load (data
not shown).
Reduced viral infectivity in IN mutant vectors
In the absence of significant differences in viral RNA
content from supernatants of wild type and integrase deficient
producer cells lines, we were interested in the ability of the
obtained viral vectors to infect murine cells. 24-h conditioned
medium from the five producer cell lines was used to infect
NIH/3T3 cells, and the infectious titre was determined both by
FACS and by counting resistant colonies after prolonged se-
lection in G418.
The amount of EGFP-expressing cells as well as the mean
fluorescent intensity (MFI) per infected cell was determined
48 h and 96 h post infection (p.i.). Using supernatant from 293-
WTvpc, the percentage of green cells as well as the MFI
differed only marginally between 48 h and 96 h, suggesting that
viral DNA was effectively integrated and the transgene
expressed by 48 h p.i. (Table 1).
In strong contrast to cells infected in the presence of wild
type IN, transduction with the IN-mutant vectors gave rise to a
very low number of green cells, which was in all cases well
below 0.1% of gated cells. To analyse this result in more detail,
EGFP-positive cells were – with respect to their fluorescent
intensity – divided into three groups, representing low (1–40),
medium (40–400) and highly (>400) fluorescing cells (Table
2). In case of all IN-mutants, higher numbers of EGFP
expressing cells were observed 48 h p.i. However, these higher
values were the result of low expressing cells comprising the
majority of EGFP positive cells 48 h p.i. By 96 h p.i., a clear
reduction in the number of low expressing cells was observed,
Fig. 3. (A) Transient infectious titre obtained for the indicated IN mutant or wild
type retroviral vectors. NIH/3T3 cells were infected with supernatants from
virus producer cells and infection efficiency was determined 96 h post infection
by FACS, as described in Materials and methods. Infectious titres are expressed
as green fluorescence units per ml supernatant (gfu/ml). (B) Stable infectious
titre obtained for the indicated IN mutant or wild type retroviral vectors. NIH/
3T3 cells were infected with supernatants from virus producer cells and
subjected to G418-selection for 2 weeks, as described in Materials and methods.
Long term infection efficiency was determined by counting the number of
G418-resistant colonies. Infectious titres are expressed as colony forming units
per ml supernatant (cfu/ml). Displayed values represent the means plus standard
deviations from two independent infection experiments, each performed in
duplicate. *The difference between the IN mutants indicated by the tips of the
brackets is statistically significant (P≤0.046). The difference between all IN
mutants and WT IN is also statistically significant in both (A and B), but not
indicated on the figure.
Table 1
Comparison of infection efficiency between 48 h p.i. and 96 h p.i. in cells
infected with WT IN vector
WT IN
% of eGFP+ cells (MFI) No. of eGFP+ cells/ml
supernatant
48 h p.i. 96 h p.i. 48 h p.i. 96 h p.i.
30.6% (346.9) 31.2% (325.0) 9.18E+05 9.36E+05
The left half of the table shows the percentage of green cells. The mean
fluorescent intensities (MFI) are given in brackets. The right part of the table
displays the number of EGFP-positive cells/ml supernatant (infectious titre).
Displayed values represent the means from two independent infection
experiments, each performed in duplicate.
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extent were essentially unaffected.
Fig. 3A shows a comparison of the total number of infected
NIH/3T3 cells using 1 ml of viral supernatant, as obtained for
vectors with wild type as well as mutant integrase. There is
clearly a strong, statistically significant (P=0.0001) deficit in
infection capability in all vectors harbouring mutant integrase as
compared to the wild type vector. Comparing differences in
infection efficiency within IN-mutants revealed that IND184N
infected cells more efficiently than IN203M15 (P=0.016), and
IN392 (P=0.046), which is probably a reflection of the lower
particle titres obtained from the respective producer cell lines
(compare Fig. 2A).
Since the retroviral vector LXSNEGFP contains a neomycin
resistance cassette, infection efficiency can also be determined
by counting G418 resistant colonies. Recipient cells were ex-
posed to geneticin from 24 h p.i. for 14 days. The number of
G418 resistant colonies per ml of viral supernatant is depicted in
Fig. 3B. Results strongly resemble the picture obtained after
FACS analysis with the wild type vector displaying titres above
1.0E+05, while infectivity with all IN-mutant vectors is strongly
reduced (P≤0.017). The fact that G418 resistant colonies were
present after infection with any of the IN-mutant vectors,
however, suggested that vector DNA was stably integrated:
either by incomplete disruption of IN-activity, or by some other
integration mechanism independent from MLV integrase.
The significant differences from IND184N to IN392 and
IN203M15, respectively, as observed in the FACS data, were
not reciprocated by the G418 data. In contrast, IN203M15 gave
rise to significantly more G418 resistant colonies than IN263
(P=0.045). The observed discrepancies probably result from
the inherent differences in assessing short term (EGFP) and longTable 2
Comparison of infection efficiencies between 48 h p.i. and 96 h p.i. in cells infected
No. of eGFP+ cells/ml supernatant
IN263 IN392
FI 0–40 40–400 >400 0–40 40–400 >40
48 h p.i. 188 23 0 248 15 0
96 h p.i. 15 23 0 8 0 0
EGFP-positive cells were, according to their individual fluorescent intensities (FI), g
populations. Displayed values represent the means from two independent infectionterm (G418 resistance) infection efficiency: transgene expres-
sion 2 weeks p.i. should come exclusively from stably in-
tegrated vectors, while expression from episomal DNA might
still be present 96 h p.i. (Yanez-Munoz et al., 2006).
Rapid loss of viral DNA forms in integrase deficient MLV
Thus far it was clear that the mutations and/or deletions in the
catalytic core and/or the C-terminus of integrase, as present inwith IN-mutant vectors
IN203M15 IND184N
0 0–40 40–400 >400 0–40 40–400 >400
330 40 10 195 60 0
10 40 0 30 68 0
rouped into low (1–40), medium (40–400) and highly (>400) fluorescing cell
experiments, each performed in duplicate.
Fig. 4. Changes of late reverse transcription products (A), and 2-LTR circles (B),
during the course of infection for wild type IN and IN-mutant vectors, assessed
by quantitative real-time PCR. Viral DNA copy number was normalized to 106
cell DNA equivalents and 1010 pU RT-activity, as explained in the text.
Displayed values represent the means from two independent infection
experiments, each performed in duplicate. Real-time PCR measurement of
each DNA sample was also performed in duplicate wells. Results of statistical
testing are omitted for reasons of clarity, but, where appropriate, mentioned in
the text.
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infect NIH/3T3 cells. Both methods which were applied to
determine infection efficiency, however, measure the comple-
tion of the entire process of infection, from cell entry to
integration and expression of the transgene, including such
significant steps as reverse transcription and nuclear entry.
Therefore, we sought to investigate the intracellular fate of the
viral DNA from shortly after cell entry up to several days post
transduction. For this purpose, a time course experiment was set
up, in which NIH/3T3 cells were incubated with supernatants
from all five producer cell lines and recipient cells were
harvested at eight different time points (2 h, 4 h, 8 h, 24 h, 48 h,
72 h, 96 h and 144 h) post infection.
Since, upon completion of reverse transcription, viral DNA
is present in different forms such as linear, 1-LTR circle, 2-LTR
circle and integrated, a real-time PCR system was developed
that would detect any form of viral DNA after the late phases of
reverse transcription (i.e. after second strand transfer). To assay
such late reverse transcription (late RT) products, a primer/
probe combination to amplify the region between the 5′ U5
region and the packaging signal was designed. This assay was
then used to determine the copy number of viral DNA in NIH/
3T3 cells, harvested at the time points mentioned above. To be
able to relate the obtained copy number to the number of cell
DNA equivalents present in the DNA-extract, a second real-
time PCR assay targeting the 18S rDNAwas used (Klein et al.,
2000). In addition, results were normalized to the RT-activity
measured in the supernatants of producer cells.
At the earliest time point (2 h), viral DNAvalues for the wild
type vector were at ∼9.0E+05 copies/1.0E+06 rDNA copies/
1.0E+10 pU RT-activity with amounts subsequently increasing
to a peak at 8 h p.i. (Fig. 4A), suggesting that by 2 h p.i. reverse
transcription was highly advanced. After the 8 h time point, the
amount of viral DNA dropped again to the 2 h level and
remained essentially unchanged until the end of the experiment
(144 h p.i.). In two integrase mutants (IN392 and IN203M15),
viral DNA readings were as high as, or higher (differences not
statistically significant, except IN203M15/WT IN at 8 h p.i.:
P=0.010) than wild type, from 2 h to 24 h p.i. IND184N values
were at 2 h p.i. slightly lower than those obtained for WT IN,
but they reached wild type levels until the 8 h timepoint
(P=0.751). In contrast, the accumulation of late RT products
from the IN263 infections was about 10-fold lower than WT IN
until 24 h p.i., and also differed significantly from the other IN-
mutants (P≤0.018 at 8 h p.i.).
Whereas in WT IN-mediated infection DNA levels dropped
only about 2.5-fold from 8 h to 144 h p.i., the amount of all
IN-mutants dropped roughly 100- to 1000-fold by the latest
time point measured. Confirming the results from FACS
analysis, wild type DNA levels did not change from 48 h to
96 h p.i., the time points analysed in FACS (Table 1). In
contrast, levels of mutant vector DNA strongly dropped,
thereby reflecting the lower number of green cells 96 h p.i.
and suggesting that the higher number of EGFP expressing
cells at 48 h p.i. was indeed at least partly due to episomal
DNA (Table 2). To investigate whether the observed drop in
IN-mutant virus DNA after 24 h p.i. could be the result ofimpaired nuclear entry, we measured the amount of 2-LTR
circles, which are generally regarded as a surrogate marker for
retroviral nuclear entry (Lewis and Emerman, 1994; Neil et
al., 2001), although a recent report suggests that 2-LTR circles
are not exclusively present in the nucleus (Serhan et al., 2004).
For this purpose, another real-time PCR assay was set up to
exclusively measure 2-LTR circles. This was accomplished by
designing primers that span the U5–U3 junction, which should
only occur in 2-LTR circles. The same DNA preparations taken
for determination of total viral DNA were used for measuring
the abundance of 2-LTR circles for all eight time points
investigated. Again, 2-LTR copy number was normalized by
factoring the amounts of 18 s rDNA and RT-activity, as des-
cribed above.
MLV 2-LTR copy number in the cells infected with wild
type vector increased up to 24 h post transduction (Fig. 4B),
i.e. after the 8 h peak in total viral DNA, since reverse-
transcribed DNA has to be translocated to the nucleus and
transformed to 2-LTR circles first, before it can be measured.
From 24 h p.i. to the end of the experiment (144 h p.i.), the
amount of wild type vector 2-LTR circles remained essentially
stable. This result was unexpected, since non-integrated DNA
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degradation and dilution in dividing cells (Butler et al., 2002).
The amounts of 2-LTR circles increased up to 24 h p.i. also in
cells infected with the IN-mutants, but thereafter copy
numbers declined. Generally, 2-LTR circle amounts were in
good correlation with late RT copy numbers (compare Figs.
2A and B). As in the results obtained with the total viral DNA
assay, IN392 and IN203M15 displayed 2-LTR circle numbers
closest to the wild type situation. The amounts of 2-LTR
circles in IND184N infected cells was slightly lower than wild
type until the 24 h peak (P≤0.050) and IN263 displayed the
lowest 2-LTR circle copy numbers, with statistically signifi-
cant differences to all other vectors at 24 h p.i. (P≤0.033).
Since 2-LTR circles clearly increased up to 24 h p.i. in all IN
mutants, the time point where total viral DNA was already
declining, we concluded that nuclear entry is most likely not
affected by the introduced mutations and the observed loss is
indeed due to a defect in integration.
Discussion
In this study, we have investigated four MLV IN mutants
containing a point mutation in the catalytic triad (IND184N),
deletions in the C-terminus (IN263, IN392), or both
(IN203M15) (Fig. 1). All experiments were performed with
viral vectors produced from three plasmid stable packaging cell
lines, thus limiting viral replication to a single cycle.
We estimated production of viral particles by measuring the
amount of viral RNA in the supernatants of stable packaging
cell lines. All IN mutants packaged similar amounts of viral
RNA as wild type virus, with values ranging from 41% to 107%
of that of wild type, indicating little effect on particle production
(Fig. 2A). Several studies reporting normal or slightly reduced
levels of capsid protein (CA), Gag–Pol precursor processing,
RT-activity and RNA packaging in HIV-1 and MLV integrase
mutants support these observations (Ansari-Lari et al., 1995;
Lai et al., 2001; Leavitt et al., 1996). However, we cannot
exclude that the morphology of the virions obtained from our
IN-mutant producer cell lines is somehow altered, as has been
shown by Engelman et al. (1995), using electron microscopy.
A statistically significant, negative influence of all tested IN-
mutations on in vitro RT-activity (Fig. 2A) was revealed by
performing a PERT-assay, which is in contrast to findings by Lai
et al. (2001), who found no differences to in vitro wild type RT-
activity in a set of MLV IN-mutant vectors, albeit different ones
to those described in this report. However, IN-RT interactions do
occur in vitro and in vivo (Hehl et al., 2004; Hu et al., 1986; Zhu
et al., 2004) and some, but not all IN-mutations have been shown
to result in reduced levels of virion-associated RT (Engelman et
al., 1995). Accordingly, we did observe statistically significant
differences between several of the IN-mutants tested.
The infectious titres of the IN mutants were determined both
by counting the percentage of green cells shortly after infection
as well as by determining G418 resistant colony numbers 2
weeks post infection. Infection efficiency in all IN mutants was
reduced by at least four logarithmic decades relative to virus
encoding WT integrase (Fig. 3A), when FACS was performed96 h post infection. Interestingly, the number of EGFP positive
cells infected with the IN mutants was considerably higher,
albeit with lower mean fluorescent intensities, when titres were
determined as soon as 48 h p.i. (Table 2). Together with the
amounts of late RT-products and 2-LTR circles at 48 h and 96 h
p.i. (Fig. 4), these data strongly suggest that short time transgene
expression in IN-mutants comes at least partly from uninte-
grated vector forms and that expression is lower, when the
vector is not integrated. Analysis of HIV-1 IN mutants in a
MAGI assay (Kimpton and Emerman, 1992) revealed that
unintegrated DNA can support viral gene expression (Ansari-
Lari et al., 1995; Engelman et al., 1995; Wiskerchen and
Muesing, 1995). This assay depends on transactivation from the
viral Tat protein and is therefore not absolutely comparable with
the experimental setup presented here. However, very recent
publications show that even EGFP expression from IN-deficient
HIV-1 vectors can be surprisingly high (Nightingale et al., 2006;
Yanez-Munoz et al., 2006).
When long-term antibiotic selection was applied to infected
cells, the resulting picture was very similar to the FACS data.
Again, a significant difference between wild type and IN-
mutant vectors in their ability to give G418-resistant colonies
was observed. None of the mutations, however, entirely
prevented the formation of neomycin resistant colonies. These
colonies are unlikely to derive from wild-type revertants, since
the tested viral vectors are not replication competent. Low
numbers of antibiotic resistant clones are, furthermore,
consistent with findings of others, who reported that neither a
point-mutation in the catalytic triad nor a 34 aa C-terminal
deletion and not even a ΔIN mutant resulted in complete
absence of integration events after selection, as did, for
example, a ΔRT-IN mutant (Lai et al., 2001). A more detailed
study of host-virus DNA junctions produced by HIV-1 IN
mutants revealed that the proviruses lacked the hallmarks of
retroviral integration (no flanking repeats of host DNA, no 3′
processing of the viral LTRs), showing that HIV-1 DNA was
most likely integrated by mechanisms other than those mediated
by integrase (Gaur and Leavitt, 1998). Such aberrant junctions
of viral and host DNA have also been identified in cells infected
with MLV integrase mutants (Hagino-Yamagishi et al., 1987),
suggesting that integration of the MLV based IN mutant vectors
in this study was also not IN-mediated.
To analyse the amounts of reverse transcription products as
direct precursors of integrated provirus, we designed a time
course experiment to monitor total viral DNA levels in cells
infected with either wild type or integrase mutant virus. This
detailed analysis not only showed that viral DNA was
synthesized to significant amounts in the infected cells, but
also enabled us to detect subtle differences among the different
IN-mutant vectors (Fig. 4A). In accordance to published data,
mutation of the catalytic centre alone (IND184N) had no
negative effect on reverse transcription (Lai et al., 2001; Leavitt
et al., 1996).
IN263, but not IN392, the latter harbouring a relatively
short deletion from the IN C-terminus (Fig. 1), was sig-
nificantly impaired in its ability to accumulate late RT
products. This finding was intriguing, since in vitro RT-activity
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(Fig. 2B) and suggested that in vivo reverse transcription was
influenced by the introduced deletion. The fact that IN203M15,
which showed normal in vivo RT-activity, also encompasses a
complete deletion of the IN C-terminus, but has an additional
deletion in the 3′ part of the catalytic core region, suggests that
MLV IN might harbour both a domain with a positive and one
with negative influence on reverse transcription in vivo. It is
further formally possible that the short stretch of nonsense
protein attached to IN203M15 (Fig. 1, hatched box) exerts a
stabilizing function on RT that is normally not present.
Additional IN-mutants would need to be constructed in order
to answer this question more completely. Our observations
regarding impaired reverse transcription in the C-terminal
mutant IN263 are supported by others, who demonstrated a
non-enzymatic, structure based role of the C-terminus in HIV-1
and MLV viral DNA synthesis (Lai et al., 2001; Wu et al.,
1999). Experiments with replicating MLV demonstrated that
28 aa from the C-terminus may be removed without discernible
impact on replication (Roth, 1991). In connection with our
results obtained with the IN392 and IN263 mutants, the
C-terminal portion that supports reverse transcription should be
located between aa278 and aa381 of MLV IN.
In contrast to wild type IN mediated infections, viral DNA in
cells infected with all of the IN mutants markedly declined after
the 8 h peak. This observation suggests that in these cells
reverse transcripts accumulate transiently, but get lost in the
course of the experiment due to the inability of the tested IN
mutants to mediate integration of viral DNA. A study from
Jonsson et al. (1996) showed that MLV IN mutants with more
than 28 aa removed from the C terminus are catalytically
inactive, which is in broad correlation with our results.
The influence of IN mutations on nuclear entry was assessed
by quantitative real-time PCR analysis of 2-LTR circles. The
differences observed in the level of 2-LTR circles correlate with
the different levels of late RT products (see Figs. 4A and B).
Thus we conclude that nuclear entry is not impaired in the
different IN mutants.
Unexpectedly, we found that in the wild type IN infected
cells, 2-LTR circles did not decline after 24 h p.i. A possible
explanation for this observation would be that the cells were
inhibited in cell division due to confluence towards the end of
the time course experiment. It has been reported that in
aphidicolin arrested cells the amount of 2-LTR circles does not
decrease after the 24 h peak (Butler et al., 2002). However, this
alone would not explain, why in the IN-mutants the 2-LTR
curves show the expected shape. Although there are no
supporting data, it is conceivable that wild type IN remains
associated with 2-LTR circles and protects them from degrada-
tion, while mutant IN loses this function.
In summary, this study allows several interesting hypotheses:
(i) full length MLV integrase is not absolutely required for its
putative stabilizing function in viral DNA synthesis. (ii) MLV
integrase mutations do not influence nuclear entry of reverse
transcribed DNA. (iii) MLV integrase might contain several
domains exerting both positive and negative influences on
reverse transcription in vivo.Further experiments are planned to clarify the results
presented in this study and to shed more light on the distinct
roles of the IN protein, which seems to have multiple functions
in the retroviral replication cycle.
Materials and methods
Plasmid constructs
Plasmids pALF, pLXSNEGFP and pGagPol.gpt have been
described earlier (Cosset et al., 1995; Klein et al., 1997;
Markowitz et al., 1988). The latter encodes a wild type MLV
integrase and thus served as basis for construction of a series of
IN mutant vectors: pIND184N was created by site-directed
mutagenesis using primer pair mut-1 (5′-ACA AGT CAA CGC
CAG CAA GT-3′)/(5′-CCC ATT GTT AGT TCC CAA TAC
CTG AG-3′) for amplification of the 5′-fragment and primer
pair mut-2 (5′-TGG GAA CTA ACA ATG GGC CTG CCT-3′)/
(5′-CGT TGA ACG CGC CAT GTC AG-3′) for amplification
of the 3′-fragment. Underlined nucleotides represent mutations
to the wild-type sequence, leading to a D–N exchange at
position 184 of the integrase. The resulting fragments were
combined in a PCR using again primers (5′-ACA AGT CAA
CGC CAG CAA GT-3′) and (5′-CGT TGA ACG CGC CAT
GTC AG-3′) and resulting in a 450 bp fragment that was
digested with NdeI/SacII and ligated into the 9467 bp NdeI/
SacII fragment of pGagPol.gpt. The resulting intermediate was
termed pIN1-264new and consecutively digested with XhoI/
NdeI. A 3842 bp XhoI/NdeI fragment of pIN1-264new was
then ligated to a 2948 bp NdeI/NdeI fragment and a 6075 bp
NdeI/XhoI fragment of pGagPol.gpt, resulting in plasmid
pIND184N. pIN203M15 was constructed in the same way as
the previous plasmid, but using a different forward primer (5′-
TGG GAA CTA ACA ATG GGC C[C]T GC-3′) for ampli-
fication of the 3′-fragment, which introduced a frame shift
downstream of the D184N mutation. The deletion mutants
pIN263 and pIN392 were constructed by PCR amplification of
a 2246 bp (pIN263) or a 2630 bp (pIN392) fragment from the
pol region of pGagPol.gpt using the reverse primer (5′-GTC
AGC AAC CAG GTG TGG AA-3′) and either of the following
forward primers: (5′-ATA TAG GCC CCC ATG GCC TCC
CCT AAT CCC CTT AAT TCT-3′) for pIN263, and (5′-TAG
GCC CCC ATG GCC TCG ACC CTG ACATGA CAA G-3′)
for pIN392. The amplification products were digested with SfiI
and each ligated into a 10408 bp SfiI fragment of pGagPol.gpt,
yielding plasmids pIN263 and pIN392.
In order to serve as a standard for the 2-LTR real-time PCR
assay (see below), plasmid p2LTRLXSN was constructed by
PCR amplification of two fragments, using pLXSNEGFP as
template: fragment 1 (1512 bp) was amplified using primers
AmpDN1 (5′-TTG CCA TTG CTG CAG GCA TC-3′) and
MSVU5DN1c (5′-AAT GAA AGA CCC CCG TCG T-3′);
fragment 2 (2418 bp) was amplified using the primer pair
MLVU3 (5′-AAT GAA AGA CCC CAC CTG TA-3′) and
AmpDN1c (5′-TAC GGA TGG CAT GAC ACT A 3′). Both
fragments were digested with PvuI and subsequently ligated,
resulting in p2LTRLXSN.
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NIH/3T3 (ATCC CRL-1687) and HEK293 cells (ATCC
CRL-1573) were cultivated in Dulbecco's Modified Eagle
Medium (DMEM, Invitrogen) with 10% fetal calf serum (FCS)
at 37 °C with 5% CO2.
For establishing stable virus producing cell lines, 1×106
HEK293 cells were transfected with 10 μg of pGagPol.gpt or
either of the IN-mutant structural vectors using the calcium
phosphate method. 24 h post transfection, cells were transferred
to medium containing 15 μg/ml hypoxanthine, 250 μg/ml
xanthine and 25 mg/ml mycophenolic acid (all Sigma) and
selected for 2 weeks. Afterwards, each of the resulting cell lines
was supertransfected with 10 μg of pLXSNEGFP and pALF.
Selection was applied for the first 2 weeks with 50 μg/ml
phleomycin (Invitrogen) afterwards the medium was changed to
contain 400 μg/ml geneticin (Invitrogen) for 2 additional weeks.
Infection experiments
For determination of infectious titre by FACS analysis,
1×105 VPC were seeded in 6-well plates 48 h prior to
transduction. The next day, cells were covered with 2 ml fresh
medium and 24 h later, 1 ml of this conditioned medium was
0.45 μm filtered and used to infect 3×105 NIH/3T3 recipient
cells. In addition, cells were infected with 1:10, 1:100* and
1:1000* (* only wild type integrase) diluted supernatant. All
infections were performed in the presence of 8 μg/ml polybrene
(Sigma). Cells were harvested 48 and 96 h p.i. and subjected to
FACS. Titres were expressed as green-fluorescence units
(GFU)/ml.
For determination of the antibiotic resistance titre, recipient
cells were treated as above, but harvested 24 h p.i. Aliquots of
the cell suspensions were seeded in 10 cm dishes and geneticin
(Invitrogen) was added after 6 h to a final concentration of
400 μg/ml. To count the G418 resistant colonies which had
formed after a selection period of 2 weeks, cells were stained
with May Gruenwald stain (Sigma). Titres were expressed as
colony-forming units (cfu)/ml.
For measuring virus DNA-copy number and 2-LTR circles,
2×106 NIH/3T3 cells were seeded in 10 cm dishes and
incubated with 2 ml of 0.45 μm-filtered, 24 h conditioned
supernatant of subconfluent virus producer cells, in the presence
of polybrene (8 μg/ml). Recipient cells were harvested at
several time points (2, 4, 8, 24, 48, 72, 96 and 144 h post
infection) and DNA was extracted using the DNeasy tissue kit
(Qiagen).
Real-time PCR assays
To estimate viral particle numbers in supernatants of virus
producing cell lines, RNA was prepared from 140 μl super-
natant using the viral RNA mini kit (Qiagen).
The real-time RT-PCR assay was performed using the
TaqMan One-Step RT-PCR Master Mix Reagents Kit (Applied
Biosystems) and contained 12.5 μl 2× Master Mix, 0.625 μl of
the 40× MultiScribe and RNAse Inhibitor Mix, 300 nM of eachprimer (EGFP214f 5′-GCA GTG CTT CAG CCG CTA C-3′;
EGFP309r 5′-AAG AAG ATG GTG CGC TCC TG-3′),
200 nM of the TaqMan probe (EGFP234p 5′-FAM-CCG
ACC ACA TGA AGC AGC ACG ACT T-TAMRA-3′), and
5 μl sample in a total reaction volume of 25 μl. After an initial
RT step of 30 min at 42 °C, followed by a denaturation step of
10 min at 95 °C, amplification was performed with 45 cycles of
15 s at 95 °C and 1 min at 60 °C. As external standard we used
RNA generated by in vitro transcription of an egfp carrying
plasmid (RiboMAX large scale RNA production systems kit,
Promega).
The 25 μl real-time PCR mixtures of the late RT real-time
PCR assay contained 3 mM MgCl2, 200 nM of each dNTP,
300 nM of primers 2LTRDN2f (5′-TCC GAATCG TGG TCT
CGC-3′) and lateRTDN2R (5′-CCA AAT CCC GGA CGA
GC-3′), 200 nM of the TaqMan probe 2LTRDNMGBp (5′-FAM-
CTC CTC TGA GTG ATT GAC-NFQ-3′), 1.25 units Ampli-
Taq Gold DNA Polymerase, 2.5 μl of the corresponding
GeneAmp 10× PCR Gold Buffer (Applied Biosystems) and 5 μl
of the extracted DNA. For the 2-LTR real-time PCR assay,
primer lateRTDN2R was exchanged to primer 2-LTRDN2r (5′-
GCT AGC TTG CCA AAC CTA CAG G-3′). After an initial
denaturation of 10 min at 95 °C, amplification was performed
with 45 cycles of 15 s at 95 °C and 1 min at 60 °C. As external
standard for the quantification of total viral cDNA and 2-LTR
circles in infected cells, serial dilutions of the respective plasmid
containing the target sequence (pLXSNEGFP and 2LTRLXSN,
respectively) were prepared.
To normalize for cell number, a rDNA real-time PCR assay
targeting the 18S rDNA genes was performed with the
following modifications to the above assays: reactions con-
tained Taq DNA polymerase enzyme, PEII Buffer (Applied
Biosystems), the forward primer rRNA343f (5′-CCA TCG
AAC GTC TGC CCT A-3′), the reverse primer rRNA409r (5′-
TCA CCC GTG GTC ACC ATG-3′) and the probe rRNA370p
(5′-FAM-CGATGG TGG TCG CCG TGC CTA-TAMRA-3′);
initial denaturation was performed for 2 min at 95 °C.
The cell number per reaction was determined using a serial
dilution of genomic DNA that had been prepared from NIH/3T3
cells stably transduced with the LXSNEGFP retroviral vector.
All of the above real-time PCRs were performed on the ABI
Prism 7700 Sequence Detection System (Applied Biosystems).
PERT-assay
Reverse transcriptase (RT) activity in virus containing cell
culture supernatants was assessed using a Product Enhanced
Reverse Transcriptase (PERT)-assay (Lovatt et al., 1999; Pyra
et al., 1994): 100 μl of 0.45 μm filtered supernatants of virus
producer cells were mixed with an equal amount of disruption
buffer (40 mM Tris–Cl, pH 8.1; 50 mM KCl; 20 mM
dithiothreitol-DTT; 0.2% Triton X-100) and incubated at
room temperature for 2 min to lyse the virions. Starting from
this 1:2 dilution, 1:10, 1:100, 1:1000 and 1:10000 dilutions
were made from each sample. As a standard, a serial dilution of
purified MoMLV RT (Promega) was used. MoMLV RT was
diluted in 1:10 steps in RT-dilution buffer (20 mM Tris–Cl, pH
58 A. Steinrigl et al. / Virology 362 (2007) 50–597.5; 50 mM KCl; 0.25 mM EDTA, pH 8.0; 0.025% Triton
X-100; 50% glycerol; 0.2 mM DTT). In the reverse transcrip-
tion step of the assay, 10 μl of either standard, sample or
negative controls (disruption or dilution buffer alone) were
incubated with 20 ng of brome mosaic virus (BMV) RNA in
25 μl reaction mixes additionally containing 10 mM Tris–Cl
(pH 8.3), 50 mM KCl, 0.35% Triton X-100, 200 μM of each
dNTPs, 5 mM MgCl2, 2 mM DTT, 1.3 μM Primer R (5′-GAT
GCT CTTATT TGC GAT CTC ACT T-3′) and 8 U RNasin, for
1 h at 37 °C. BMV DNA, generated during the RT-step, was
quantified by real-time PCR in 50 μl reaction mixes containing
25 μl RT-mixes plus 10 mM Tris–Cl (pH 8.8), 200 μM of each
dNTP, 1 μM primer F (5′-TGA AGG AAT TTG TGC GTTATT
GTA A-3′), 1 μM primer R, 0.3 μM probe (5′-FAM-TCT TCG
TCA CCT ATG GGA CAT TTC CGG-TAMRA-3′), 500 ng
RNase A, 50 nM ROX and 2.5 U AmpliTaq Gold. PCR was
performed with a 7500 PCR Detection System (Applied Bio-
systems) using the following conditions: initial denaturation at
95 °C for 2 min, followed by 45 cycles with 95 °C for 15 sec and
60 °C for 1 min.
Statistical analysis
Statistical significance of all experimental data sets was
assessed using a two-tailed t-test, performed with the Microsoft
Excel programme. A P-value ≤0.05 was considered as a sta-
tistically significant difference.
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